Thailand · Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 5.50 billion. The enterprise value is 5.51 billion.
| Market Cap | 5.50B |
| Enterprise Value | 5.51B |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 66.16% |
| Owned by Institutions (%) | 0.84% |
| Float | 73.27M |
Valuation Ratios
The trailing PE ratio is 15.15 and the forward PE ratio is 13.94. BKK:KLINIQ's PEG ratio is 1.06.
| PE Ratio | 15.15 |
| Forward PE | 13.94 |
| PS Ratio | 1.55 |
| PB Ratio | 3.09 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | 15.25 |
| P/OCF Ratio | 8.32 |
| PEG Ratio | 1.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.80, with an EV/FCF ratio of 15.28.
| EV / Earnings | 15.15 |
| EV / Sales | 1.55 |
| EV / EBITDA | 6.80 |
| EV / EBIT | 11.55 |
| EV / FCF | 15.28 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.21 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | 1.88 |
| Interest Coverage | 18.12 |
Financial Efficiency
Return on equity (ROE) is 20.81% and return on invested capital (ROIC) is 22.08%.
| Return on Equity (ROE) | 20.81% |
| Return on Assets (ROA) | 9.24% |
| Return on Invested Capital (ROIC) | 22.08% |
| Return on Capital Employed (ROCE) | 20.58% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 526 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 5.36 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 97.00 million in taxes.
| Income Tax | 97.00M |
| Effective Tax Rate | 21.04% |
Stock Price Statistics
The stock price has decreased by -18.03% in the last 52 weeks. The beta is 0.16, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -18.03% |
| 50-Day Moving Average | 22.72 |
| 200-Day Moving Average | 23.84 |
| Relative Strength Index (RSI) | 65.58 |
| Average Volume (20 Days) | 225,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.56 billion and earned 363.70 million in profits. Earnings per share was 1.65.
| Revenue | 3.56B |
| Gross Profit | 1.80B |
| Operating Income | 477.21M |
| Pretax Income | 461.05M |
| Net Income | 363.70M |
| EBITDA | 810.33M |
| EBIT | 477.21M |
| Earnings Per Share (EPS) | 1.65 |
Balance Sheet
The company has 717.31 million in cash and 677.45 million in debt, with a net cash position of 39.85 million or 0.18 per share.
| Cash & Cash Equivalents | 717.31M |
| Total Debt | 677.45M |
| Net Cash | 39.85M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 1.78B |
| Book Value Per Share | 8.06 |
| Working Capital | 217.59M |
Cash Flow
In the last 12 months, operating cash flow was 660.77 million and capital expenditures -300.15 million, giving a free cash flow of 360.62 million.
| Operating Cash Flow | 660.77M |
| Capital Expenditures | -300.15M |
| Free Cash Flow | 360.62M |
| FCF Per Share | 1.64 |
Margins
Gross margin is 50.51%, with operating and profit margins of 13.42% and 10.23%.
| Gross Margin | 50.51% |
| Operating Margin | 13.42% |
| Pretax Margin | 12.96% |
| Profit Margin | 10.23% |
| EBITDA Margin | 22.79% |
| EBIT Margin | 13.42% |
| FCF Margin | 10.14% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 5.62%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 5.62% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 87.71% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 5.74% |
| Earnings Yield | 6.61% |
| FCF Yield | 6.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |